| Species | Disruptability | Reference | Submitter |
|---|---|---|---|
| P. falciparum 3D7 |
Refractory |
22127061 | Theo Sanderson, Wellcome Trust Sanger Institute |
| P. falciparum 3D7 |
Possible |
29042501 Crispr successfully targeted gene with no difference in asexual bloodstage growth. Gametocytes round up but males fail to exflagellate and there is no subsequent infection of mosquitoes. |
Theo Sanderson, Wellcome Trust Sanger Institute |
| P. falciparum 3D7 |
Possible |
USF piggyBac screen (Insert. mut.) | USF PiggyBac Screen |
| Species | Stage | Phenotype | Reference | Submitter |
|---|---|---|---|---|
| P. falciparum 3D7 | Asexual |
No difference |
29042501 Crispr successfully targeted gene with no difference in asexual bloodstage growth. Gametocytes round up but males fail to exflagellate and there is no subsequent infection of mosquitoes. |
Theo Sanderson, Wellcome Trust Sanger Institute |
| P. falciparum 3D7 | Gametocyte |
Attenuated |
29042501 Crispr successfully targeted gene with no difference in asexual bloodstage growth. Gametocytes round up but males fail to exflagellate and there is no subsequent infection of mosquitoes. |
Theo Sanderson, Wellcome Trust Sanger Institute |
| PlasmoDB | PF3D7_0610600 |
| GeneDB | PF3D7_0610600 |
| Malaria Metabolic Pathways | Localisation images Pathways mapped to |
| Previous ID(s) | 2270.t00209, MAL6P1.108, PFF0520w |
| Orthologs | |
| Google Scholar | Search for all mentions of this gene |